Safety, tolerability, and single- and multiple-dose pharmacokinetics of piperaquine phosphate in healthy subjects

Journal of Clinical Pharmacology
Tausif AhmedVijay Batra

Abstract

Piperaquine phosphate is an orally active bisquinolone antimalarial drug that has been used for the past 3 decades. The authors report the safety, tolerability, and pharmacokinetics of piperaquine from a classical controlled phase I study. It was a double-blind, randomized, parallel-group, placebo-controlled, and single- and multiple-dose study. During the rising single-dose study, single ascending oral doses of 500, 750, 1000, 1250, and 1500 mg of piperaquine phosphate were administered, whereas in rising multiple-dose study, once-daily ascending oral doses of 500, 750, 1000, and 1500 mg were administered for 3 consecutive days. Pharmacokinetic analysis for both the rising single- and multiple-dose studies was done using the noncompartmental approach. The mean apparent terminal half-life ranged from 11 to 23 days. Increase in exposure was less than dose proportional and linear. Piperaquine concentrations were measurable up to 60 days postdose. Multiple peaks were observed in the plasma piperaquine concentration-time profiles and exhibited 3- to 7-fold accumulation following multiple dosing. Piperaquine was well tolerated following single and multiple doses.

References

Jun 12, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Te-Yu HungKenneth F Ilett
Mar 5, 2004·British Journal of Clinical Pharmacology·Te-Yu HungDoung Socheat
Dec 22, 2004·Drugs·Timothy M E DavisKenneth F Ilett
May 21, 2005·Journal of Pharmaceutical and Biomedical Analysis·N LindegårdhN P J Day
May 27, 2005·Antimicrobial Agents and Chemotherapy·Ing-Kye SimKenneth F Ilett
Nov 24, 2005·Antimicrobial Agents and Chemotherapy·Joel TarningNicholas J White
Mar 30, 2006·European Journal of Clinical Pharmacology·Daniel RöshammarMichael Ashton

❮ Previous
Next ❯

Citations

Jun 29, 2011·Antimicrobial Agents and Chemotherapy·Anna AnnerbergFrançois Nosten
Nov 3, 2010·Annual Review of Pharmacology and Toxicology·Thomas E Scammell, Christopher J Winrow
Feb 26, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Offianan Andre TourePaul Swoboda
Oct 30, 2010·Trends in Parasitology·Ronan JambouMilijaona Randrianarivelojosia
Nov 7, 2009·Reproductive Toxicology·Kevin T BattyTimothy M E Davis
Nov 9, 2015·European Journal of Drug Metabolism and Pharmacokinetics·Iftekhar MahmoodRita Humeniuk
Aug 6, 2014·Antimicrobial Agents and Chemotherapy·S M D K Ganga Senarathna, Kevin T Batty
Jun 3, 2016·Expert Review of Anti-infective Therapy·Johannes MischlingerMichael Ramharter
Jul 12, 2017·British Journal of Clinical Pharmacology·Palang ChotsiriJoel Tarning

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.